Back

Pyrophosphate scintigram as a potential imaging index of therapeutic efficacy for transthyretin cardiac amyloidosis

31 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Shunsuke Saito

Jichi Medical University, Shimotsuke (Japan)

4 More presentations in this session

Presentation thumbnail
Two-year cardiac follow-up of transthyretin amyloid deposition in surgical specimens from carpal tunnel syndrome and rotator cuff tear cases
Assistant Professor T. Umemoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Spatial transcriptomics of human cardiac biopsy samples reveals gene expression signature of cardiac amyloidosis
Mr S. Saito (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Cardiac transthyretin amyloidosis in patients with conduction system disease
Doctor J. Pudich (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
Acoramidis-mediated improvement in NT-proBNP at month 30 compared with placebo in patients with ATTR-CM: results from the ATTRibute-CM study
Doctor N. Sarswat (Chicago, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

31 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of 99mTc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis
thumbnail
Congress Presentation
Monitoring amyloidosis treatment
thumbnail
Congress Presentation
Serial changes of 99mTc- pyrophosphate uptake in patients with hereditary transthyretin amyloid cardiomyopathy treated with tafamidis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources